FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313892771> ?p ?o ?g. }

• W4313892771 endingPage "2237" @default.
• W4313892771 startingPage "2227" @default.
• W4313892771 abstract "To report the incidence and risk factors for secondary neoplasm after transplantation for sickle cell disease.Included are 1,096 transplants for sickle cell disease between 1991 and 2016. There were 22 secondary neoplasms. Types included leukemia/myelodysplastic syndrome (MDS; n = 15) and solid tumor (n = 7). Fine-Gray regression models examined for risk factors for leukemia/MDS and any secondary neoplasm.The 10-year incidence of leukemia/MDS was 1.7% (95% CI, 0.90 to 2.9) and of any secondary neoplasm was 2.4% (95% CI, 1.4 to 3.8). After adjusting for other risk factors, risks for leukemia/MDS (hazard ratio, 22.69; 95% CI, 4.34 to 118.66; P = .0002) or any secondary neoplasm (hazard ratio, 7.78; 95% CI, 2.20 to 27.53; P = .0015) were higher with low-intensity (nonmyeloablative) regimens compared with more intense regimens. All low-intensity regimens included total-body irradiation (TBI 300 or 400 cGy with alemtuzumab, TBI 300 or 400 cGy with cyclophosphamide, TBI 200, 300, or 400 cGy with cyclophosphamide and fludarabine, or TBI 200 cGy with fludarabine). None of the patients receiving myeloablative and only 23% of those receiving reduced-intensity regimens received TBI.Low-intensity regimens rely on tolerance induction and establishment of mixed-donor chimerism. Persistence of host cells exposed to low-dose radiation triggering myeloid malignancy is one plausible etiology. Pre-existing myeloid mutations and prior inflammation may also contribute but could not be studied using our data source. Choosing conditioning regimens likely to result in full-donor chimerism may in part mitigate the higher risk for leukemia/MDS." @default.
• W4313892771 created "2023-01-10" @default.
• W4313892771 creator A5000669662 @default.
• W4313892771 creator A5002479426 @default.
• W4313892771 creator A5003639088 @default.
• W4313892771 creator A5004619630 @default.
• W4313892771 creator A5006173110 @default.
• W4313892771 creator A5006845399 @default.
• W4313892771 creator A5009145909 @default.
• W4313892771 creator A5011386306 @default.
• W4313892771 creator A5013802810 @default.
• W4313892771 creator A5024412886 @default.
• W4313892771 creator A5038535078 @default.
• W4313892771 creator A5040299600 @default.
• W4313892771 creator A5041346359 @default.
• W4313892771 creator A5050109992 @default.
• W4313892771 creator A5054037976 @default.
• W4313892771 creator A5055330139 @default.
• W4313892771 creator A5056346259 @default.
• W4313892771 creator A5056651771 @default.
• W4313892771 creator A5064328568 @default.
• W4313892771 creator A5073597251 @default.
• W4313892771 creator A5075831275 @default.
• W4313892771 creator A5084043008 @default.
• W4313892771 creator A5087504195 @default.
• W4313892771 creator A5087536541 @default.
• W4313892771 creator A5091433944 @default.
• W4313892771 date "2023-04-20" @default.
• W4313892771 modified "2023-10-17" @default.
• W4313892771 title "Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease" @default.
• W4313892771 cites W1958271975 @default.
• W4313892771 cites W1996223831 @default.
• W4313892771 cites W2001175629 @default.
• W4313892771 cites W2001176345 @default.
• W4313892771 cites W2017398926 @default.
• W4313892771 cites W2020551482 @default.
• W4313892771 cites W2023449596 @default.
• W4313892771 cites W2038981426 @default.
• W4313892771 cites W2044507524 @default.
• W4313892771 cites W2065982504 @default.
• W4313892771 cites W2071068942 @default.
• W4313892771 cites W2093382617 @default.
• W4313892771 cites W2101839601 @default.
• W4313892771 cites W2152197116 @default.
• W4313892771 cites W2163964555 @default.
• W4313892771 cites W2467516479 @default.
• W4313892771 cites W2552002719 @default.
• W4313892771 cites W2562103559 @default.
• W4313892771 cites W2609610302 @default.
• W4313892771 cites W2622355165 @default.
• W4313892771 cites W2747626317 @default.
• W4313892771 cites W2751401377 @default.
• W4313892771 cites W2902667388 @default.
• W4313892771 cites W2921636184 @default.
• W4313892771 cites W2936876518 @default.
• W4313892771 cites W2942121536 @default.
• W4313892771 cites W2946523097 @default.
• W4313892771 cites W2946533897 @default.
• W4313892771 cites W2964691922 @default.
• W4313892771 cites W2971545858 @default.
• W4313892771 cites W3006523030 @default.
• W4313892771 cites W3024374829 @default.
• W4313892771 cites W3024470836 @default.
• W4313892771 cites W3093490071 @default.
• W4313892771 cites W3119773089 @default.
• W4313892771 cites W3171725975 @default.
• W4313892771 cites W3199502236 @default.
• W4313892771 cites W4200515132 @default.
• W4313892771 cites W4205491223 @default.
• W4313892771 cites W4220893957 @default.
• W4313892771 cites W4224311738 @default.
• W4313892771 cites W4293919120 @default.
• W4313892771 doi "https://doi.org/10.1200/jco.22.01203" @default.
• W4313892771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36623245" @default.
• W4313892771 hasPublicationYear "2023" @default.
• W4313892771 type Work @default.
• W4313892771 citedByCount "4" @default.
• W4313892771 countsByYear W43138927712023 @default.
• W4313892771 crossrefType "journal-article" @default.
• W4313892771 hasAuthorship W4313892771A5000669662 @default.
• W4313892771 hasAuthorship W4313892771A5002479426 @default.
• W4313892771 hasAuthorship W4313892771A5003639088 @default.
• W4313892771 hasAuthorship W4313892771A5004619630 @default.
• W4313892771 hasAuthorship W4313892771A5006173110 @default.
• W4313892771 hasAuthorship W4313892771A5006845399 @default.
• W4313892771 hasAuthorship W4313892771A5009145909 @default.
• W4313892771 hasAuthorship W4313892771A5011386306 @default.
• W4313892771 hasAuthorship W4313892771A5013802810 @default.
• W4313892771 hasAuthorship W4313892771A5024412886 @default.
• W4313892771 hasAuthorship W4313892771A5038535078 @default.
• W4313892771 hasAuthorship W4313892771A5040299600 @default.
• W4313892771 hasAuthorship W4313892771A5041346359 @default.
• W4313892771 hasAuthorship W4313892771A5050109992 @default.
• W4313892771 hasAuthorship W4313892771A5054037976 @default.
• W4313892771 hasAuthorship W4313892771A5055330139 @default.
• W4313892771 hasAuthorship W4313892771A5056346259 @default.
• W4313892771 hasAuthorship W4313892771A5056651771 @default.
• W4313892771 hasAuthorship W4313892771A5064328568 @default.

• next